MedTrace Logo

The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block

NCT06130514 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2024-05-29

No results posted yet for this study

Summary

For patients scheduled to undergo upper limb sympathetic nerve block due to chronic neuropathic pain in the upper limb lasting more than 3 months, the ultrasound-guided stellate ganglion block group (S group) and the fluoroscopy-guided thoracic sympathetic nerve block group (T) Patients are randomly assigned 1:1 to one of the groups, and the procedure is performed. To evaluate the effectiveness of sympathetic nerve blockade, temperature changes in both palms are measured twice, 20 minutes before and 20 minutes after the procedure, using an infrared thermographer. Other variables related to the procedure are surveyed by outpatient visit or telephone before the procedure, after the procedure, before returning home, and 1 week and 1 month after the procedure.

Conditions

  • Chronic Pain
  • Neuropathic Pain
  • Complex Regional Pain Syndromes
  • Post Herpetic Neuralgia
  • Post Laminectomy Syndrome

Interventions

DEVICE

Ultrasound

Ultrasound-guided stellate ganglion block with 1% mepivacaine 5 mL

DEVICE

Fluoroscopy

Fluoroscopic-guided thoracic sympathetic ganglion block with 1% mepivacaine 3 mL

Sponsors & Collaborators

  • Seoul National University

    lead OTHER

Principal Investigators

  • Jee Youn Moon, MD, PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-10
Primary Completion
2025-12-10
Completion
2026-01-10

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06130514 on ClinicalTrials.gov